{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:15:55Z","timestamp":1696331755798},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Due to lack of treatment options for early acute allograft dysfunction in the presence of tubular-interstitial injury without histological features of rejection, kidney transplant recipients are often treated with sirolimus-based therapy to prevent cumulative calcineurin inhibitor exposure and to prevent premature graft failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed transplant recipients treated with sirolimus-based (n = 220) compared with continued tacrolimus-based (n = 276) immunosuppression in recipients of early-onset graft dysfunction (threatened allograft) with the use of propensity score-based inverse probability treatment weighted models to balance for potential confounding by indication between 2 nonrandomized groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Weighted odds for death-censored graft failure (odds ratio [OR], 1.20; 95% confidence interval [95% CI], 0.66-2.19, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.555) was similar in the 2 groups, but a trend for increased risk of greater than 50% loss in estimated glomerular filtration rate from baseline in sirolimus group (OR, 1.90; 95% CI, 0.96-3.76; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.067) compared with tacrolimus group. Sirloimus group compared with tacrolimus group had increased risk for death with functioning graft (OR, 2.01; 95% CI, 1.29-3.14; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002) as well as increased risk of late death (death after graft failure while on dialysis) (OR, 2.39; 95% CI, 1.59-3.59; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Analysis of subgroups based on the absence or presence of T cell\u2013mediated rejection or tubulointerstitial inflammation in the index biopsy, or the use of different types of induction agents, and all subgroups had increased risk of death with functioning graft and late death if exposed to sirolimus-based therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Use of sirolimus compared with tacrolimus in recipients with early allograft dysfunction during the first year of transplant may not prevent worsening of allograft function and could potentially lead to poor survival along with increased risk of late death.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000000585","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T16:15:37Z","timestamp":1470932137000},"page":"e98","source":"Crossref","is-referenced-by-count":0,"title":["Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study"],"prefix":"10.1097","volume":"2","author":[{"given":"Ravinder K.","family":"Wali","sequence":"first","affiliation":[{"name":"Transplant Division, Department of Surgery and Medicine, Inova Health System. Falls Church, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Prentice","sequence":"additional","affiliation":[{"name":"Transplant Division, Department of Surgery and Medicine, Inova Health System. Falls Church, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Reddivari","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geroge","family":"Baffoe-Bonnie","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthia I.","family":"Drachenberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Pappadimitriou","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Ramos","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Transplant Surgery, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Jonsson","sequence":"additional","affiliation":[{"name":"Transplant Division, Department of Surgery and Medicine, Inova Health System. Falls Church, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Transplant Surgery, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Weir","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2016,9]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamasurg.2014.2038","article-title":"SUrvival benefit of solid-organ transplant in the United States","volume":"150","year":"2015","journal-title":"JAMA Surgery"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMp1114394","article-title":"Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","year":"2002","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"bib9-20231002","first-page":"i3","article-title":"Renal function as a predictor of long-term graft survival in renal transplant patients","volume":"18","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/j.1600-6143.2005.00983.x","article-title":"Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.TP.0000061602.03327.E2","article-title":"Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation","volume":"75","year":"2003","journal-title":"Transplantation"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1600-6143.2011.03911.x","article-title":"Kidney allograft inflammation and fibrosis, causes and consequences","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI41789","article-title":"A molecular classifier for predicting future graft loss in late kidney transplant biopsies","volume":"120","year":"2010","journal-title":"J Clin Invest"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ajt.12080","article-title":"Kidney transplants with progressing chronic diseases express high levels of acute kidney injury transcripts","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/ctr.12074","article-title":"Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype","volume":"27","year":"2013","journal-title":"Clin Transplant"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","article-title":"Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1600-6143.2009.02727.x","article-title":"Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1681\/ASN.2010010049","article-title":"Fibrosis with inflammation at one year predicts transplant functional decline","volume":"21","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-6143.2009.02938.x","article-title":"Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib22-20231002","first-page":"750602","article-title":"The Interplay between inflammation and fibrosis in kidney transplantation","volume":"2014","year":"2014","journal-title":"BioMed Res Int"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3181b723f4","article-title":"Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil","volume":"88","year":"2009","journal-title":"Transplantation"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1600-6143.2005.00811.x","article-title":"Kidney allograft fibrosis and atrophy early after living donor transplantation","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1997.38","article-title":"Early protocol renal allograft biopsies and graft outcome","volume":"51","year":"1997","journal-title":"Kidney Int"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/01.ASN.0000054496.68498.13","article-title":"Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies","volume":"14","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-6143.2011.03505.x","article-title":"Chronic progressive calcineurin nephrotoxicity: an overstated concept","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","year":"2004","journal-title":"Transplantation"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1600-6143.2011.03718.x","article-title":"Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-6143.2009.02943.x","article-title":"Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/j.1600-6143.2007.01892.x","article-title":"Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000079390","article-title":"Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function","volume":"24","year":"2004","journal-title":"Am J Nephrol"},{"key":"bib35-20231002","first-page":"466","article-title":"Mycophenolate Mofetil Creeping Creatinine Study G. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the \u201ccreeping creatinine\u201d study","volume":"79","year":"2005","journal-title":"Transplantation"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e318224c12d","article-title":"Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study","volume":"92","year":"2011","journal-title":"Transplantation"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","article-title":"Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the postconcept study","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled spare-the-nephron trial","volume":"79","year":"2011","journal-title":"Kidney Int"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","year":"2009","journal-title":"Transplantation"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2009.02954.x","article-title":"Pathological and clinical characterization of the \u2018troubled transplant\u2019: data from the DeKAF study","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/j.1600-6143.2004.00585.x","article-title":"Banff 2003 meeting report: new diagnostic insights and standards","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","year":"2003","journal-title":"Am J Epidemiol"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a009758","article-title":"Confounding by indication: an example of variation in the use of epidemiologic terminology","volume":"149","year":"1999","journal-title":"Am J Epidemiol"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","article-title":"Adjusted survival curves with inverse probability weights","volume":"75","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/sim.1903","article-title":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study","volume":"23","year":"2004","journal-title":"Stat Med"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1093\/ndt\/gfr163","article-title":"Inflammation-associated graft loss in renal transplant recipients","volume":"26","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1046\/j.1523-1755.2002.00149.x","article-title":"Molecular and structural consequences of early renal allograft injury","volume":"61","year":"2002","journal-title":"Kidney Int"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1600-6143.2010.03312.x","article-title":"The histology of solitary renal allografts at 1 and 5 years after transplantation","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1523-1755.2001.0590041567.x","article-title":"Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy","volume":"59","year":"2001","journal-title":"Kidney Int"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-6143.2011.03826.x","article-title":"Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-6143.2012.04281.x","article-title":"Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","year":"2009","journal-title":"Nature"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2215\/CJN.03820609","article-title":"Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm","volume":"4","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1034\/j.1600-6143.2002.21015.x","article-title":"Death after graft loss: an important late study endpoint in kidney transplantation","volume":"2","year":"2002","journal-title":"Am J Transplant"},{"key":"bib56-20231002","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1111\/j.1600-6143.2012.04235.x","article-title":"Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years","volume":"12","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201609000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:03:16Z","timestamp":1696230196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201609000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000585","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}